Menopause is the point in a woman's life when
she has not had a
menstrual period for 1 year. Menopause marks the end
of the childbearing years. It is sometimes called 'the change of life.'
For most women, menopause happens around age 50, but every woman's body
has its own timeline. Some women stop having periods in their mid-40s. Others
continue well into their 50s.
Perimenopause
is the process of change that leads up to menopause. It can start as early as
your late 30s or as late as your early 50s. How long perimenopause lasts
varies, but it usually lasts from 2 to 8 years. You may have irregular periods
or other symptoms during this time.
Menopause is a natural part of
growing older. You don't need treatment for it unless your symptoms bother you.
But it's a good idea to learn all you can about menopause. Knowing what to
expect can help you stay as healthy as possible during this new phase of your
life.
What causes menopause?
Normal changes in your
reproductive and hormone systems cause menopause. As your egg supply ages, your
body begins to
ovulate less often. During this time, your
hormone levels go up and down unevenly (fluctuate),
causing changes in your periods and other symptoms. In time,
estrogen and
progesterone levels drop enough that the menstrual
cycle stops.
Some medical treatments can cause your periods to
stop before age 40. Having your ovaries removed,
radiation therapy, or
chemotherapy can trigger early menopause.
What are the symptoms?
Common symptoms include:
Irregular periods. Some women have light
periods. Others have heavy bleeding. Your menstrual cycle may be longer or
shorter, or you may skip periods.
Emotional
changes. Some women have mood swings or feel grouchy, depressed, or worried.
Headaches.
Feeling that your heart is beating too
fast or unevenly (palpitations).
Problems with remembering
or thinking clearly.
Vaginal dryness.
Some women have only a few mild symptoms. Others have
severe symptoms that disrupt their sleep and daily lives.
Symptoms tend to last or get worse the first year or more after
menopause. Over time, hormones even out at low levels, and many symptoms
improve or go away. Then you can enjoy being free from periods and birth
control concerns.
Do you need tests to diagnose menopause?
You don't
need to be tested to see if you have started perimenopause or reached
menopause. You and your doctor will most likely be able to tell based on
irregular periods and other symptoms.
If you have heavy,
irregular periods, your doctor may want to do tests to rule out a serious cause
of the bleeding. Heavy bleeding may be a normal sign of perimenopause. But it
can also be caused by infection, disease, or a pregnancy problem.
You may not need to see your doctor about menopause symptoms. But it is
important to keep up your annual physical exams. Your risks for heart disease,
cancer, and bone thinning (osteoporosis) increase after menopause.
At your yearly visits, your doctor can check your overall health and recommend
testing as needed.
Do you need treatment?
Menopause is a natural part
of growing older. You don't need treatment for it unless your symptoms bother
you. But if your symptoms are upsetting or uncomfortable, you don't have to
suffer through them. There are treatments that can help.
The first
step is to have a healthy lifestyle. This can help reduce symptoms and also
lower your risk of heart disease and other long-term problems related to
aging.
Make a special effort to eat well. Choose a
heart-healthy diet that is low in saturated fat and includes plenty of fish,
fruits, vegetables, beans, and high-fiber grains and breads.
Include plenty of calcium in your diet to help your bones stay strong. Get
1,200 mg a day after age 50 (plus at least 400 IU of vitamin D to help your
body use the calcium). Low-fat or nonfat dairy products are a great source of
calcium.
Get regular exercise. Exercise can help you manage your
weight, keep your heart and bones strong, and lift your mood.
Limit caffeine, alcohol, and stress. These things can make symptoms worse.
Limiting them may help you sleep better.
If you smoke, stop.
Quitting smoking can reduce hot flashes and long-term health risks.
If lifestyle changes are not enough to relieve your
symptoms, you can try other measures, such as:
Meditative breathing exercise (called paced
respiration). Breathing exercises may help reduce hot flashes and emotional
symptoms.
Black cohosh. This herb may prevent or relieve symptoms.
But experts don't know about its long-term safety. You should not take it if
there is a chance you could be pregnant. If you plan to try black cohosh, talk
to your doctor about how to take it safely.
Soy (isoflavones).
Some women feel that eating lots of soy helps even out their menopause
symptoms. It may also help keep your bones strong after menopause.1
Yoga or biofeedback to help reduce stress. High
stress is likely to make your symptoms worse.
If you have severe symptoms, you may want to ask your
doctor about prescription medicines. Choices include:
A medicine called clonidine
(Catapres) that is usually used to treat high blood pressure.
All medicines for menopause symptoms have possible risks
or side effects. A very small number of women develop serious health problems
when taking hormone therapy. Be sure to talk to your doctor about your possible
health risks before you start a treatment for menopause symptoms.
Remember, it is still possible to become pregnant until you reach
menopause. To prevent an unwanted pregnancy, keep using birth control until you
have not had a period for 1 full year.
Health Tools
Health Tools help you make wise health decisions or take action to improve your health.
Decision Points focus on key medical care decisions that are important to many health problems.
As you age, your body begins the
natural sequence of changes that eventually bring an end to your
menstrual cycle (menopause). The number and quality of
your eggs decline,
hormone levels fluctuate, and your menstrual cycle
becomes less predictable. This time of unpredictable change is called
perimenopause.
Menopause and postmenopause
After a few years of
fluctuating hormones, your
estrogen and
progesterone levels begin to decline. When your
estrogen drops past a certain point, your menstrual cycle and your ability to
become pregnant end. After 1 year with no menstrual bleeding, you reach
menopause and begin postmenopause.
A year or more into
postmenopause, estrogen levels typically even out at a low level. Since
estrogen also plays a role in other functions of your body, its decline has
far-reaching effects, including faster bone loss and drying and thinning of the
skin and the vaginal and urinary tracts.
Menopause can be caused
suddenly and prematurely by surgical removal of the ovaries (oophorectomy), by
chemotherapy, or by
radiation therapy to the abdomen or pelvis.
Causes of early menopause
Your body has its own
timeline for when menopause will start and how long it will last. In fact, it's
likely that your timeline will be much like your mother's was. But certain
lifestyle choices and medical treatments can cause or are linked to an earlier
menopause, including:
Smoking. On average, women who smoke reach
menopause 1½ years earlier than those who don't. The longer you have smoked and
the more you smoke, the stronger this effect is likely to be.2
Although some women have few or no
menopause symptoms, most women do. Similarly, while
some women have mild symptoms, others find that their sleep, daily life, and
sense of well-being are severely affected. Menopause symptoms eventually
subside when hormone levels even out.
Postmenopause changes are normal signs of low estrogen
and typically continue over time.
Signs and symptoms of perimenopause
Signs that you
are in perimenopause include:
Irregular menstrual periods.
Less frequent, light menstrual periods.
Heavier
menstrual periods than you are used to having.
Symptoms of menopause
Symptoms related to menopause are caused by changing or dropping hormone
levels and usually end 1 or 2 years after menopause. Some women continue to
have symptoms for 5 or more years afterward. Menopause symptoms include:
Emotional changes, such as mood
swings or irritability.
A change in sexual interest or
response.
Problems with concentration and memory that are linked to
sleep loss and fluctuating hormones (not a permanent sign of aging).3
Headaches.
Rapid, irregular
heartbeats (heart palpitations).
Generalized itching.
These symptoms are not only caused by menopause. They can
be caused by other medical problems. If your symptoms are troubling you, talk
with your doctor.
Menopause caused by surgery,
chemotherapy, or
radiation therapy can cause more severe symptoms than
usual. Preexisting conditions such as
depression,
anxiety, sleep problems, or irritability can get worse
during perimenopause.
Signs of postmenopause
Signs that you have
reached menopause and are in postmenopause include:
No menstrual periods (and no need for birth
control measures).
Drying and thinning of the skin, caused by lower
collagen production.
Other conditions can cause changes in the menstrual
cycle or symptoms resembling perimenopause and postmenopause. Examples include
pregnancy, a significant change in weight, depression, anxiety, disease, or
uterine, thyroid, or pituitary problems.
What Happens
In your late 30s, your
egg supply begins to decline in number and quality. As a result, your
hormone production changes-you may notice a shortened menstrual cycle and some
premenstrual syndrome (PMS) symptoms that you didn't
have before.
Perimenopause
As your egg supply continues to
decline, your
ovulation and menstruation become irregular. This can
start as early as your late 30s or as late as your early 50s. It continues for
2 to 8 years before menstrual cycles end. During this time, your ovaries are
sometimes producing too much
estrogen and/or
progesterone and at other times too little. Your
progesterone is likely to fluctuate more than before, which can lead to
heavy menstrual bleeding. (If you have heavy or
unexpected vaginal bleeding, see your doctor to be sure it is not caused by a
more serious condition.)
Menopause
About 6 months to a year before your
periods stop, your estrogen starts to drop. When it drops past a certain point,
your menstrual cycles stop. After a year of no menstrual periods, you are said
to have "reached menopause."
Postmenopause
During the first year or so after
menopause,
estrogen levels continue to decline. It's normal to
continue having symptoms, such as hot flashes or insomnia, during the first
year or two after menopause. After your hormone levels reach a stable low
point, these symptoms are likely to subside. But some women continue to have
symptoms for years, perhaps because their estrogen levels are particularly low.
(After menopause, body fat tissue continues to produce estrogen. Women with low
body fat tend to have lower estrogen levels.)
Low estrogen is part
of the healthy, natural state of postmenopause. Low estrogen reduces your
cancer risk (estrogen is linked to some types of cancerous cell growth). But
because it also plays an important role in skin and bone health, low estrogen
creates some health concerns for the postmenopausal woman.
Bone loss. Low
estrogen levels after menopause speed bone loss, increasing your risk of
osteoporosis.
Skin changes. Low estrogen leads to low
collagen, which is a building block of skin and
connective tissue. It's normal to have thinner, dryer, wrinkled skin after
menopause. The vaginal lining and the lower urinary tract also thin and weaken.
This condition can make sexual activity difficult and can increase the risk of
vaginal and urinary tract infections.
Tooth and gum changes. Low estrogen
affects connective tissue, which increases your risk of tooth loss and possibly
gum disease.4
Although the reasons are not well understood,
a woman's risk of heart disease increases after menopause. Because heart
disease is the number one killer of women, consider your heart risk factors
when making lifestyle and treatment decisions.
Perimenopause symptoms, such as
insomnia,
hot flashes, or mood swings, that aren't responding to
home treatment and are interfering with your sleep or daily
life.
Menopause is a normal process of
hormone change and doesn't require treatment. If your
menopause symptoms are mild, try home treatment for
relief. Discuss your symptoms with your doctor at your next regular
exam.
Who to See
The following health professionals can
help you manage menopause symptoms and evaluate menstrual period
changes:
You and your doctor can tell whether
you are in
perimenopause based on your age, your history of
menstrual periods, your symptoms, and the results of your
pelvic exam. If possible, bring a calendar or journal
of your menstrual period and symptoms.
If you have severe symptoms
before or after menopause, if your doctor suspects another medical condition,
or if you have a medical condition that makes a diagnosis difficult, your
doctor may do one or more of the following tests:
A
pregnancy test is done if there is a chance that you
are pregnant.
A
follicle-stimulating hormone (FSH) test can be used to
confirm whether you have reached menopause.
FSH levels increase during perimenopause and are high
after menopause.
An
estrogen test is sometimes done to see how low
estrogen has dropped after menopause.
A
thyroid-stimulating hormone test is used to see
whether irregular menstrual periods or perimenopause-like symptoms are being
caused by a thyroid problem.
If you have had no menstrual periods for 1 year, you have
reached menopause and are in
postmenopause. This is a good time to have a full
physical exam, with particular focus on your heart health and risk factors for
osteoporosis. Be sure to report to your doctor any
unexpected vaginal bleeding.
Unexpected vaginal or menstrual bleeding
If you have irregular bleeding during
perimenopause or you are taking continuous
hormone therapy and have vaginal bleeding after 6 to
12 months of treatment, your doctor may use one or more additional tests to
rule out serious causes of the bleeding. These tests may include:
All women age 65 and older should have a routine
bone mineral density test to screen for
osteoporosis. If you are at increased risk for
osteoporosis, your routine screening should begin earlier, at age 60. If you
have stopped hormone therapy, it is very important to discuss osteoporosis
screening with your doctor. This is because you no longer have the extra bone
protection from extra estrogen.
Most experts say that the decision
to screen women age 60 and younger should be made on an individual basis. This
decision depends on your risk for developing osteoporosis and whether the test
results could help with treatment decisions. For more information, see the
topic
Osteoporosis.
Treatment Overview
Menopause is a natural change
that doesn't require treatment. But symptoms of hormonal change can be
difficult. If you have
insomnia, mood swings,
hot flashes, cloudy thinking,
heavy menstrual periods, or other menopause symptoms,
treatment can help you manage this transition more comfortably. As you review
your options, consider the following:
Healthy lifestyle habits will help you reduce
menopause symptoms. These habits include eating a balanced diet; reducing
stress; getting regular exercise; and avoiding smoking, heavy caffeine, and
heavy alcohol use. An unhealthy lifestyle can make symptoms worse.
Low-dose
hormone therapy (HT) or low-dose birth control pills
may be an option if you are still having periods and have multiple or severe
symptoms. Birth control pills aren't used after menopause because they contain
higher levels of hormones than women need.
After menopause,
hormone therapy can be used as a
short-term treatment for severe symptoms when taken in
as low a dose as possible.
You may only need a specific treatment
for certain symptoms, such as hot flashes or vaginal dryness.
Meditative breathing or supplements such as black cohosh or soy
may help relieve symptoms.
Research has led to a big change in how doctors use
hormone therapy after menopause. For a long time,
estrogen-progestin, or hormone replacement therapy (HRT), was thought to protect against heart disease or dementia. But
studies now show that HRT use can cause serious health problems in a small
number of women. These health problems include dangerous blood clots, stroke,
heart disease, breast cancer, ovarian cancer, and dementia.5, 6, 7 The heart
disease risk does not seem to affect women during their first 10 years after
menopause.8
Average HRT- and ERT-related
risks are low among the general population of women. But your personal risk that hormone therapy may stimulate breast cancer, ovarian
cancer, cardiovascular problems, blood clots, or neurological changes may be
lower or higher, depending on your risk factors for those health problems.
Vaginal dryness and irritation. A vaginal lubricant can help
with dryness.
Low-dose vaginal estrogen can help if your symptoms
are thin skin, dryness, and/or irritation. Less estrogen is absorbed into your
system with vaginal use, so the risks associated with ERT are less likely.
Multiple or severe symptoms.Hormone therapy can relieve multiple or difficult
menopause symptoms. For symptom relief before menopause,
low-dose estrogen-progestin birth control pills or
low-dose HRT (estrogen-progestin) can reduce heavy
menstrual bleeding and other symptoms. After menopause, low-dose HRT is an
option. Also, for severe symptoms that don't improve with estrogen-progestin,
there is an
estrogen-testosterone therapy. But testosterone is not
FDA-approved for women, because it is not yet well studied. Talk to your doctor
about
short-term HRT along with checkups every 6 months.
Bioidentical hormone replacement therapy (BHRT) is an
alternative to HRT. But it has not been well studied. The hormones are made in
a laboratory from wild yams or soy. BHRT is thought to be more similar to
human-produced hormones than synthetic HRT is. (Well-designed studies have not
yet proved this theory.12) But bioidentical HRT may
carry the same heart, stroke, blood clot, breast cancer, ovarian cancer, and
dementia risks that are linked to traditional HRT. Any form of hormone therapy,
including BHRT, is best taken for as short a period as possible after
menopause.
Testosterone is sometimes used to increase sexual
desire in postmenopausal women who have low testosterone. But the U.S. Food and
Drug Administration (FDA) has not approved testosterone treatment for this
purpose. There is no testosterone product that comes in doses that are right
for women. Studies of testosterone in women have not lasted longer than 6
months.13 FDA experts want to know more about
long-term risks before they approve testosterone for use by females.
If you have a problem with low sexual desire, consider that most sexual
problems in women relate to such things as relationship troubles, depression,
or medicine side effects. For more information, see the topic
Sexual Problems in Women.
Other treatment options
Women may also try
alternative medicine to relieve menopause symptoms. These alternatives may
include
black cohosh (Remifemin) or
dietary soy. For more information about alternative
treatments, see the Other Treatment section.
Hormone Therapy: A Shift in Thinking
Changes in hormone replacement therapy (HRT)
Over the past decades,
hormone replacement therapy (HRT) was thought to offer
health- and youth-preserving benefits to
postmenopausal women. But recent studies have led to a
dramatic shift from this way of thinking.
One large study done by
the
Women's Health Initiative (WHI) has shown that HRT
does not protect against heart disease. In fact, in a small number of women who
are 10 or more years past menopause, it causes heart disease, including
heart attacks.8 In the WHI
study, short-term use of HRT was also linked to an
increase in the numbers of
strokes and
blood clots. Using HRT for several years was linked to
increased cases of
breast cancer and
dementia. Overall, most women using HRT in the WHI
study had no serious side effects, but they also had no long-term
benefits.
Among all women, average hormone therapy risks are very
low. Your personal risks may be lower or higher than the
average. This depends on your risk factors for breast cancer, ovarian cancer,
cardiovascular problems, blood clots, or dementia.
Based on the
WHI study, the U.S. Food and Drug Administration (FDA) has updated its HRT
recommendations. Estrogen-progestin HRT is approved for:
Short-term treatment of menopause
symptoms. HRT effectively relieves menopause symptoms for most women. Women who
decide that HRT benefits outweigh their risks are advised to use the lowest
effective dose for as short a time as possible.9 For
most women, menopause symptoms naturally improve within a few years' time,
making long-term symptom treatment unnecessary.
Osteoporosis prevention and treatment, in select
cases. Most experts recommend that long-term HRT only be considered for women
with a high osteoporosis risk. In this case, estrogen's bone-protecting benefit
may outweigh the risks of taking HRT. Women are now encouraged to consider all
possible osteoporosis treatments and to compare their risks and
benefits.14
Changes in estrogen replacement therapy (ERT)
Women who have early, sudden menopause after a
hysterectomy with both
ovaries removed are usually advised to use
estrogen replacement therapy (ERT) to protect against
bone loss. The low estrogen levels of menopause cause bone thinning. Compared
to women who are not taking hormone therapy, women taking ERT have fewer hip
fractures (a sign of estrogen's bone-protecting effect).15
ERT also helps with menopausal symptoms. Known
ERT risks come from studies of women older than 50. It may be that the benefits
outweigh the risks for younger women who take ERT until the age of natural
menopause.16 This question needs further
research.
The Women's Health Initiative (WHI) studied
estrogen-only therapy in older women and found that it increases the risks of
blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism) and the risk of
stroke during the first year of use.15 ERT may increase the risk of
dementia in women who are older than 65.17 ERT offered no protection against heart disease. In fact, it
was linked to heart disease and ovarian cancer in a small number of
women.8, 18
Some
studies have found a possible link between ERT and breast cancer.19 In the WHI trial, women using ERT had no increase in breast
cancer risk during the study's nearly 7 years of ERT treatment.15 But the Million Women Study of British women ages 50 to 64
suggests that after 10 years of taking
ERT, a small number of women develop breast cancer that is related to ERT.6, 20
(Many women in this age group also develop breast cancer without taking hormone
therapy.)
If you have had breast cancer or ovarian cancer, do not
take ERT or HRT.19
Short-term HRT or ERT
effectively relieves hot flashes and vaginal dryness for most women, though
side effects are common. Side effects that lead women to stop HRT include
unpredictable menstrual-like bleeding, breast tenderness, and
depression.21
Short-term, low-dose HRT or ERT is hoped to offer a balance between HRT benefits and
risks. It can be taken for 4 to 5 years, with regular checkups. This may work
well for many women, who will find that their menopause symptoms have subsided
within this period of time. As more healthy postmenopausal women use low-dose
hormones for shorter periods of time, researchers will be able to evaluate the
actual benefits and risks.
If you are taking long-term HRT or ERT, talk to your doctor about whether its benefits outweigh its risks,
considering your own needs, age, and health history. For you, the increased
risks of
breast cancer,
heart attack,
stroke, blood clots, and
dementia may be small. Or, if you have a personal or
family history of breast cancer or heart disease, HRT risks may outweigh HRT
benefits.
Stopping HRT or ERT. Talk to
your doctor before you stop hormone therapy. There is no way of knowing in
advance whether you will have menopause symptoms when you stop using estrogen.
About 70% of women who stop HRT have tolerable symptoms or no symptoms at all.
The remaining 30% have symptoms that are less tolerable or more
long-lasting.22
Home Treatment
The years just before and after
menopause (perimenopause
and
postmenopause) are an especially important time of
your life to treat your body well. If you haven't been, now is the time to
start.
If you smoke, stop smoking to reduce hot
flashes and long-term health risks.
Exercise regularly
to promote both physical and emotional health.
Make
healthy eating a priority. Reduce your consumption of
simple sugars and caffeine, which can make menopause symptoms worse. You'll not
only feel better but may also prevent long-term health problems.
Pay attention to how the
emotional side of menopause is affecting you. Have a
support network, and seek help as needed.
If you have symptoms of perimenopause, you may be able to
handle them with self-care measures. Practical ways to manage
hot flashes include keeping your environment cool, dressing in layers, and
managing stress, especially with slow, rhythmic breathing (paced respiration)
or relaxation exercises. Measures to
improve vaginal dryness and muscle tone include using
a vaginal lubricant and doing
Kegel exercises regularly.
As the body ages, the risks of developing heart disease,
osteoporosis, and other long-term health problems
naturally increase. Your most powerful preventive and antiaging medicine is a
healthy lifestyle.
Research has changed how doctors use
hormone therapy after menopause. For a long time, hormone replacement therapy
(HRT) was thought to protect against heart disease and dementia. But studies
now show that HRT use can cause serious health problems. One large study done
by the
Women's Health Initiative (WHI) has shown that HRT
does not protect against heart disease. In fact, in a small number of women who
are 10 or more years past menopause, it causes heart disease, including
heart attacks.8 In the WHI
study, short-term use of HRT was also linked to an
increase in the numbers of
strokes and
blood clots. Using HRT for several years was linked to
increased cases of
breast cancer and
dementia. Overall, most women using HRT in the WHI
study had no serious side effects, but they also had no long-term
benefits.
ERT may also cause breast cancer in a small number of
women.6
Experts do not yet know whether
hormone therapy risks are the same for older and younger postmenopausal women.
Researchers are now exploring HRT use by women who use short-term, low-dose
hormone therapy starting at menopause.
Average HRT- and
ERT-related risks are low among the general population of women.
Your personal risks that hormone therapy may stimulate
breast cancer, cardiovascular problems, blood clots, or neurological changes
may be lower or higher, depending on your risk factors.
Many
doctors now suggest trying nonhormonal treatment for bothersome
menopause symptoms before considering hormone therapy
(birth control pills, estrogen alone [ERT], or estrogen-progestin [HRT]). There
are several nonhormonal prescription treatments that can relieve or reduce hot
flashes and other menopause symptoms. You can also try using
black cohosh or
dietary soy.
Medication Choices
Prescription medication without hormones
Antidepressant medicines can lower the number and
severity of hot flashes. Some women have side effects.10 The safety of very long-term use has yet to be
studied.
Clonidine, a high blood pressure medicine, can reduce
the number and severity of hot flashes.11 Some women
have side effects related to low blood pressure.
Gabapentin (Neurontin), an antiseizure medicine, can
reduce the number and severity of hot flashes.23
Possible side effects include sleepiness, dizziness, and swelling.
Prescription medication with hormones
Birth control pills (estrogen and
progestin) regulate menstrual bleeding and can relieve symptoms until
menopause. Birth control pills are not used after menopause. You should not use
birth control pills if you smoke or have
diabetes, untreated high blood pressure,
cardiovascular disease, or a history of breast cancer. Low-dose formulations
are recommended for women older than 35. Some women have side
effects.
Progestin pills or the
levonorgestrel IUD, which releases a form of
progesterone into the uterus, reduce heavy, irregular menstrual periods during
perimenopause. Some women have side effects.
Hormone replacement therapy (estrogen and progestin),
in pill, patch, vaginal ring, gel, or cream form, can be used to treat
menopause symptoms. Because studies have found that HRT increases some health
risks for some women, doctors have changed the way HRT is used. For menopause
symptom relief, experts now recommend that HRT only be used at the lowest
effective dose for the shortest possible period of time.9
Bioidentical hormone replacement therapy is made from plants and is thought to be more similar to
human-produced hormones than synthetic HRT. But bioidentical HRT is not well
researched and may carry the same health risks that traditional HRT
does.9 Any form of hormone therapy is best taken for
as short a period as possible.
Estrogen replacement therapy (ERT) is used to prevent
weakening bones and the severe symptoms that come with sudden, early menopause.
Early menopause usually happens after surgery to remove the uterus and ovaries
(hysterectomy and oophorectomy) or from ovary failure
after cancer treatment. But ERT is known to slightly increase the risks of
stroke and blood clots during the first year of use.20
Long-term ERT may slightly increase breast and ovarian cancer risks.6, 18
Taking estrogen by
itself (ERT) can lead to
uterine (endometrial) cancer. Taking progestin with
estrogen protects against uterine cancer. This is why ERT is only recommended
if you have no uterus. If you have not had your uterus removed and want hormone
therapy, you take progestin with the estrogen (HRT).
Short-term, low-dose HRT or ERT is hoped to offer a balance between HRT benefits and risks. It can
be taken for up to 4 to 5 years, with regular checkups. This may work well for
many women, who will find that their menopause symptoms have subsided within
this period of time. As more women use low-dose hormones for shorter periods of
time after menopause, researchers will be able to learn about the actual
benefits and risks.
Progesterone creams.
"Natural"
progesterone creams (available in health food stores
or through mail order) or prescription
progestin creams, which are made by a compounding
pharmacist, are marketed to correct low
progesterone levels. While some women report finding
relief with progesterone cream, there is mixed evidence about whether these
products increase the body's progesterone levels.24, 25, 26 This
raises the following concerns about over-the-counter progesterone cream use.
If it is absorbing well. Progesterone treatment has risks. It has been linked to breast
cancer, headaches, and dangerous blood clots in a small number of
women.26 This is why progesterone is usually a
prescription hormone and is not safe for women with certain health
risks.
If it is not absorbing well. If you
are taking estrogen (and have an intact uterus), you also need to have enough
progesterone to prevent the estrogen from causing
uterine (endometrial) cancer. Using a poorly absorbed
progesterone cream while taking estrogen does not protect you from uterine
cancer.25
Talk to your doctor before using an over-the-counter
progesterone cream.
Testosterone.Testosterone-estrogen is sometimes used for menopausal
symptoms that don't improve with estrogen therapy. But it is not FDA-approved
because its risks are not yet fully known. Testosterone-estrogen carries the
same risks as estrogen treatment (blood clots, stroke, breast cancer) as well
as testosterone risks and side effects. Experts have not studied long-term
risks of testosterone-estrogen use, but it is known that testosterone treatment
can cause hair loss, acne, deepening of the voice, and facial hair
growth.9
Testosterone is sometimes used to increase sexual
desire in postmenopausal women who have low testosterone. But, no form of
testosterone is approved for women. Studies have not shown a benefit for longer
than 12 weeks of use, and long-term testosterone risks for women are not yet
known.13 If you have a problem with decreased sexual
desire, consider that most sexual troubles in women relate to such things as
relationship problems, depression, or medicine side effects. For more
information, see the topic
Sexual Problems in Women.
What to Think About
HRT and osteoporosis. Researchers are studying the effects of low-dose estrogen
therapy. A small early study has shown that a low estrogen dose-0.25 mg a day-may keep the bones as strong as the higher
dose.27 But the long-term risks of taking low-dose
estrogen are not yet known.
Other Treatment
Because of concern about
hormone replacement therapy (HRT) health risks, many
women have turned to alternative medicine for menopause symptom relief. As part
of a stepwise treatment approach, you can consider using one or more of the
following options for preventing or treating symptoms before trying
prescription medicines or hormones.
The meditative breathing exercise called
paced respiration may reduce hot flashes and emotional symptoms. This approach
has no known side effects, risks, or costs and can be safely combined with
additional treatment, if needed.
Black cohosh (Remifemin, 20 mg) may prevent or relieve menopause symptoms. But the research on black
cohosh has had mixed results. Some studies have shown that black cohosh can
relieve hot flashes.24 But other studies have shown
that black cohosh does not relieve hot flashes.28 Also,
the long-term safety is not yet known. (Risks similar to estrogen risks are a
possibility.) Have regular checkups if you are using black cohosh, and make
sure your doctor knows what you are taking.
Soy phytoestrogens (isoflavones) are in more complete form when you eat them as food,
rather than in a pill or powder. A high-soy diet has been linked to stronger
bones, especially in the first 10 years after menopause, when estrogen levels
drop and rapid bone loss happens.1 Regularly eating
and drinking soy may also help even out menopause symptoms. But studies have
shown mixed results. They have not always shown that soy is effective for
treating hot flashes.29
Yoga (which often includes meditative breathing)
and/or
biofeedback give you tools you can use to reduce
stress. High stress is likely to make your symptoms worse.
Alternative treatments to avoid
Based on the
latest research, some therapies are not recommended for menopause symptoms,
either because they are not effective or because they can cause dangerous
effects. These include:
These types of
medicinals are not required to have the same testing or purity standards as
prescription and other nonprescription medicines. The amount of a drug in
herbal preparations varies widely. It is also possible for nonregulated
products to be contaminated with metals or other dangerous substances. Before
trying any treatment, look for scientific studies that support its beneficial
claims as well as information on risks. When buying herbs or supplements:
Find a reputable brand or supplier.
Look for the U.S. Pharmacopeia (USP)-verified mark on product
labels. This is one way of finding a product that has been tested for safety
and quality. For more information, see
www.usp.org/USPVerified/dietarySupplements.
If you are using an alternative medicine or herbal
remedy, make sure your doctor knows. Tell him or her the type and amount you
are taking, how long you have been taking it, and why.
Other Places To Get Help
Organizations
American Botanical Council (ABC)
P.O. Box 144345
Austin, TX 78714
Phone:
1-800-373-7105
Fax:
(512) 926-2345
E-mail:
abc@herbalgram.org
Web Address:
www.herbalgram.org
The American Botanical Council's goals are to educate
the public about beneficial herbs and plants and to promote the safe and
effective use of medicinal plants.
American College of Obstetricians and Gynecologists
(ACOG)
409 12th Street SW
P.O. Box 96920
Washington, DC 20090-6920
Phone:
(202) 638-5577
E-mail:
resources@acog.org
Web Address:
www.acog.org
American College of Obstetricians and Gynecologists
(ACOG) is a nonprofit organization of professionals who provide health care for
women, including teens. The ACOG Resource Center publishes manuals and patient
education materials. The Web publications section of the site has patient
education pamphlets on many women's health topics, including reproductive
health, breast-feeding, violence, and quitting smoking.
American Heart Association (AHA)
7272 Greenville Avenue
Dallas, TX 75231
Phone:
1-800-AHA-USA1 (1-800-242-8721)
Web Address:
www.americanheart.org
Call the American Heart Association (AHA) to find your
nearest local or state AHA group. AHA can provide brochures and information
about support groups and community programs, including Mended Hearts, a
nationwide organization whose members visit people with heart problems and
provide information and support. AHA's Web site also has information on
physical activity, diet, and various heart-related conditions.
National Cancer Institute (NCI)
NCI Publications Office
6116 Executive Boulevard
Suite 3036A
Bethesda, MD 20892-8322
Phone:
1-800-4-CANCER (1-800-422-6237) 9:00 a.m. to 4:30 p.m. EST, Monday through Friday
TDD:
1-800-332-8615
E-mail:
cancergovstaff@mail.nih.gov
Web Address:
www.cancer.gov (or
https://cissecure.nci.nih.gov/livehelp/welcome.asp# for live help
online)
The National Cancer Institute (NCI) is a U.S. government agency
that provides up-to-date information about the prevention, detection, and
treatment of cancer. NCI also offers supportive care to people with cancer and
to their families. NCI information is also available to doctors, nurses, and
other health professionals. NCI provides the latest information about clinical
trials. The Cancer Information Service, a service of NCI, has trained staff
members available to answer questions and send free publications.
Spanish-speaking staff members are also available.
National Center for Complementary and Alternative
Medicine (NCCAM) Clearinghouse
P.O. Box 7923
Gaithersburg, MD 20898
Phone:
1-888-644-6226 (301) 519-3153 for international calls
Fax:
1-866-464-3616 toll-free
TDD:
1-866-464-3615 toll-free
E-mail:
info@nccam.nih.gov
Web Address:
www.nccam.nih.gov/health/clearinghouse (or
www.nccaminfo.org/livehelp/ for live help online)
The National Center for Complementary and Alternative Medicine
(NCCAM) at the National Institutes of Health (NIH) explores complementary and
alternative healing practices in the context of rigorous science, trains
complementary and alternative medicine researchers, and gives out authoritative
information. Send all requests for information and questions about NCCAM to the
NCCAM Clearinghouse.
National Women's Health Information
Center
8270 Willow Oaks Corporate Drive
Fairfax, VA 22031
Phone:
1-800-994-9662 (202) 690-7650
Fax:
(202) 205-2631
TDD:
1-888-220-5446
Web Address:
www.womenshealth.gov
The National Women's Health Information Center (NWHIC)
is a service of the U.S. Department of Health and Human Services Office on
Women's Health. NWHIC provides women's health information to a variety of
audiences, including consumers, health professionals, and researchers.
North American Menopause Society
(NAMS)
P.O. Box 94527
Cleveland, OH 44101-4527
Phone:
(440) 442-7550
Fax:
(440) 442-2660
E-mail:
info@menopause.org
Web Address:
www.menopause.org
The North American Menopause Society (NAMS) is a nonprofit
organization that promotes the understanding of menopause and thereby improves
the health of women as they approach menopause and beyond. NAMS members include
experts from medicine, nursing, sociology, psychology, nutrition, anthropology,
epidemiology, pharmacy, and education. The NAMS Web site has information on
perimenopause, early menopause, menopause symptoms and long-term health effects
of estrogen loss, and a variety of therapies.
United States Pharmacopeia (USP)
12601 Twinbrook Parkway
Rockville, MD 20852-1790
Phone:
1-800-227-8772
Web Address:
www.usp.org
The United States Pharmacopeia (USP) sets standards for
drug and dietary supplement quality to ensure that the general public receives
good and safe pharmaceutical care. USP standards help to assure consumers that
the medicines they take are of high quality, consistent in ingredients and
strength, and properly labeled and stored. In the relatively unregulated arena
of dietary supplements, USP's verification program provides the answer to
important consumer questions.
Zhang X, et al. (2005). Prospective cohort study of
soy food consumption and risk of bone fracture among postmenopausal women.
Archives of Internal Medicine, 165(16):
1890-1895.
Speroff L, Fritz MA (2005). Menopause and the
perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 621-688. Philadelphia:
Lippincott Williams and Wilkins.
Joffe H, et al (2003). Assessment and treatment of hot
flushes and menopausal mood disturbance. Psychiatric Clinics of North America, 26(3): 563-580.
Taguchi A, et al. (2004). Effect of estrogen use on
tooth retention, oral bone height, and oral bone porosity in Japanese
postmenopausal women. Menopause, 11(5):
556-562.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
Shumaker SA, et al. (2003). Estrogen plus progestin
and the incidence of dementia and mild cognitive impairment in postmenopausal
women. The Women's Health Initiative memory study: A randomized controlled
trial. JAMA, 289(20): 2651-2662.
Rossouw JE, et al. (2007). Postmenopausal hormone
therapy and risk of cardiovascular disease by age and years since menopause.
JAMA, 297(13): 1465-1477.
North American Menopause Society (2004). Treatment of
menopause-associated vasomotor symptoms: Position statement of the North
American Menopause Society. Menopause, 11(1):
11-33.
Stearns V, et al. (2003). Paroxetine controlled
release in the treatment of menopausal hot flashes: A randomized controlled
trial. JAMA, 289(21): 2827-2834.
Pandya KJ, et al. (2000). Oral clonidine in
postmenopausal patients with breast cancer experiencing tamoxifen-induced hot
flashes: A University of Rochester Cancer Center Community Clinical Oncology
Program study. Annals of Internal Medicine, 132(10):
788-793.
Watt PJ, et al. (2003). A holistic programmatic
approach to natural hormone replacement. Family and Community Health, 26(1): 53-63.
North American Menopause Society (2005). The role of
testosterone therapy in postmenopausal women: Position statement of the North
American Menopause Society. Menopause, 12(5):
497-511.
American College of Obstetricians and Gynecologists
(2003). Statement of the American College of Obstetricians and Gynecologists on
hormone therapy for the prevention and treatment of postmenopausal
osteoporosis. ACOG News Release. Available online:
http://www.acog.com/from_home/publications/press_releases/nr10-07-03.cfm.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
North American Menopause Society (2007). Position
statement: Estrogen and progestogen use in peri- and postmenopausal women:
March 2007 position statement of the North American Menopause Society.
Menopause, 14(2): 168-182.
Espeland MA, et al. (2004). Conjugated equine
estrogens and global cognitive function in postmenopausal women: Women's Health
Initiative Memory Study. JAMA, 291(24):
2959-2968.
Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703-1710.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Breast cancer. Obstetrics and Gynecology, 104(4, Suppl): 11S-16S.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S-105S.
Speroff L, Fritz MA (2005). Postmenopausal hormone
therapy. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 689-777. Philadelphia: Lippincott Williams and
Wilkins.
Grady D, et al. (2003). Predictors of difficulty when
discontinuing postmenopausal hormone therapy. Obstetrics and Gynecology, 102(6): 1233-1239.
Guttuso T Jr, et al. (2003). Gabapentin's effects on
hot flashes in postmenopausal women: A randomized controlled trial.
Obstetrics and Gynecology, 101(2): 337-345.
American College of Obstetricians and Gynecologists
(2001, reaffirmed 2006). Use of botanicals for management of menopausal
symptoms. ACOG Practice Bulletin No. 28. Obstetrics and Gynecology, 97(6, Suppl): 1-11.
Cooper A, et al. (1998). Systemic absorption of
progesterone from Progest cream in post-menopausal women. Lancet, 351(9111): 1255-1256.
Hermann AC, et al. (2005). Over-the-counter
progesterone cream produces significant drug exposure compared to a Food and
Drug Administration-approved oral progesterone product. Journal of Clinical Pharmacology, 45(6): 614-619.
Prestwood KM, et al. (2003). Ultralow-dose micronized
17 B-estradiol and bone density and bone metabolism in older women.
JAMA, 290(8): 1042-1048.
Newton KM, et al. (2006). Treatment of vasomotor
symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy,
or placebo. Annals of Internal Medicine, 145(12):
869-879.
Grady D (2006). Management of menopausal symptoms.
New England Journal of Medicine, 355(22):
2338-2347.
Other Works Consulted
American Association of Clinical Endocrinologists
Menopause Guidelines Revision Task Force (2006). American Association of
Clinical Endocrinologists medical guidelines for clinical practice for the
diagnosis and treatment of menopause. Endocrine Practice, 12(3): 315-337.
Grady D, Barrett-Connor E (2008). Menopause. In L
Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp.
1857-1868. Philadelphia: Saunders Elsevier.
Shifren JL, Schiff I (2007). Menopause. In JS Berek,
ed., Berek and Novak's Gynecology, 14th ed., pp.
1323-1340. Philadelphia: Lippincott Williams and Wilkins.
U.S. Preventive Services Task Force (2005). Hormone
therapy for the prevention of chronic conditions in postmenopausal women:
Recommendations from the U.S. Preventive Services Task Force. Annals of Internal Medicine, 142(10): 855-860.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Zhang X, et al. (2005). Prospective cohort study of
soy food consumption and risk of bone fracture among postmenopausal women.
Archives of Internal Medicine, 165(16):
1890-1895.
Speroff L, Fritz MA (2005). Menopause and the
perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 621-688. Philadelphia:
Lippincott Williams and Wilkins.
Joffe H, et al (2003). Assessment and treatment of hot
flushes and menopausal mood disturbance. Psychiatric Clinics of North America, 26(3): 563-580.
Taguchi A, et al. (2004). Effect of estrogen use on
tooth retention, oral bone height, and oral bone porosity in Japanese
postmenopausal women. Menopause, 11(5):
556-562.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
Shumaker SA, et al. (2003). Estrogen plus progestin
and the incidence of dementia and mild cognitive impairment in postmenopausal
women. The Women's Health Initiative memory study: A randomized controlled
trial. JAMA, 289(20): 2651-2662.
Rossouw JE, et al. (2007). Postmenopausal hormone
therapy and risk of cardiovascular disease by age and years since menopause.
JAMA, 297(13): 1465-1477.
North American Menopause Society (2004). Treatment of
menopause-associated vasomotor symptoms: Position statement of the North
American Menopause Society. Menopause, 11(1):
11-33.
Stearns V, et al. (2003). Paroxetine controlled
release in the treatment of menopausal hot flashes: A randomized controlled
trial. JAMA, 289(21): 2827-2834.
Pandya KJ, et al. (2000). Oral clonidine in
postmenopausal patients with breast cancer experiencing tamoxifen-induced hot
flashes: A University of Rochester Cancer Center Community Clinical Oncology
Program study. Annals of Internal Medicine, 132(10):
788-793.
Watt PJ, et al. (2003). A holistic programmatic
approach to natural hormone replacement. Family and Community Health, 26(1): 53-63.
North American Menopause Society (2005). The role of
testosterone therapy in postmenopausal women: Position statement of the North
American Menopause Society. Menopause, 12(5):
497-511.
American College of Obstetricians and Gynecologists
(2003). Statement of the American College of Obstetricians and Gynecologists on
hormone therapy for the prevention and treatment of postmenopausal
osteoporosis. ACOG News Release. Available online:
http://www.acog.com/from_home/publications/press_releases/nr10-07-03.cfm.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
North American Menopause Society (2007). Position
statement: Estrogen and progestogen use in peri- and postmenopausal women:
March 2007 position statement of the North American Menopause Society.
Menopause, 14(2): 168-182.
Espeland MA, et al. (2004). Conjugated equine
estrogens and global cognitive function in postmenopausal women: Women's Health
Initiative Memory Study. JAMA, 291(24):
2959-2968.
Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703-1710.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Breast cancer. Obstetrics and Gynecology, 104(4, Suppl): 11S-16S.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S-105S.
Speroff L, Fritz MA (2005). Postmenopausal hormone
therapy. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 689-777. Philadelphia: Lippincott Williams and
Wilkins.
Grady D, et al. (2003). Predictors of difficulty when
discontinuing postmenopausal hormone therapy. Obstetrics and Gynecology, 102(6): 1233-1239.
Guttuso T Jr, et al. (2003). Gabapentin's effects on
hot flashes in postmenopausal women: A randomized controlled trial.
Obstetrics and Gynecology, 101(2): 337-345.
American College of Obstetricians and Gynecologists
(2001, reaffirmed 2006). Use of botanicals for management of menopausal
symptoms. ACOG Practice Bulletin No. 28. Obstetrics and Gynecology, 97(6, Suppl): 1-11.
Cooper A, et al. (1998). Systemic absorption of
progesterone from Progest cream in post-menopausal women. Lancet, 351(9111): 1255-1256.
Hermann AC, et al. (2005). Over-the-counter
progesterone cream produces significant drug exposure compared to a Food and
Drug Administration-approved oral progesterone product. Journal of Clinical Pharmacology, 45(6): 614-619.
Prestwood KM, et al. (2003). Ultralow-dose micronized
17 B-estradiol and bone density and bone metabolism in older women.
JAMA, 290(8): 1042-1048.
Newton KM, et al. (2006). Treatment of vasomotor
symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy,
or placebo. Annals of Internal Medicine, 145(12):
869-879.
Grady D (2006). Management of menopausal symptoms.
New England Journal of Medicine, 355(22):
2338-2347.